40.70 USD
↘ 0.68 (1.64%)AT CLOSE (03:59 PM EST)
Novo-Nordisk A/S
NVONYSE • USD
40.73
↗ 0.03 (0.07%)
POST MARKET (AS OF 06:00 PM EST)
Post Market
AS OF 06:00 PM EST
40.73
↗ 0.03 (0.07%)
Market: OPEN
NVO is currently priced at $40.73. The technical outlook is "Buy" based on moving average alignment, RSI, and MACD signals. Notable factors include a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of Nov 10, 2026.
Open?$40.71
High?$40.81
Low?$40.38
Prev. Close?$41.38
Volume?6.5M
Avg. Volume?N/A
VWAP?$40.62
Bid / Ask
Bid?$40.62 × 900
Ask?$40.70 × 200
Spread?$0.08
Midpoint?$40.66
Valuation & Ratios
Market Cap?182.4B
Shares Out?3.4B
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Themes
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestModerate
Short Interest?38.3M
Days to Cover?4.0
Avg Daily Volume9.5M
Settlement Date2026-10-30